1 Oral glucose stimulates the release of the endogenous incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulin-releasing polypeptide (GIP)
Some studies, according to the Stanford School of Medicine, have shown results around addiction treatment, from opioids to alcohol, nicotine and more
Food and Drug Administration (2023) Jardiance highlights of prescribing information, The U.S
To view or add a comment, sign in Lilly's Triple Agonist, Retatrutide, Shines in First Phase 3 Trial Retatrutide is a first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist
Very low-carb diets may be a poorer fit on reta than on GLP-1-only drugs because reta also activates the glucagon receptor, which promotes glycogen breakdown
Report Vision Changes Immediately: Any sudden changes in vision, such as blurriness, dark spots, or loss of peripheral vision, should be addressed with a healthcare provider as soon as possible